Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,052
archived clinical trials in
Nephrology

Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1022
493
mi
from 43215
Lake Success, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1022
493
mi
from 43215
Lake Success, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1353
493
mi
from 43215
Manhasset, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1353
493
mi
from 43215
Manhasset, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1355
477
mi
from 43215
New York, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1355
477
mi
from 43215
New York, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1356
348
mi
from 43215
Charlotte, NC
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1356
348
mi
from 43215
Charlotte, NC
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site
1
mi
from 43215
Columbus, OH
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site
1
mi
from 43215
Columbus, OH
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1366
525
mi
from 43215
Charleston, SC
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1366
525
mi
from 43215
Charleston, SC
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1026
362
mi
from 43215
Chattanooga, TN
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1026
362
mi
from 43215
Chattanooga, TN
Aliskiren in Patients With Idiopathic Membranous Nephropathy
A Pilot Study to Evaluate the Antiproteinuric Effect of Renin Inhibition With Aliskiren in Patients With Idiopathic Membranous Nephropathy
Status: Archived
Mayo Clinic College of Medicine
559
mi
from 43215
Rochester, MN
Aliskiren in Patients With Idiopathic Membranous Nephropathy
A Pilot Study to Evaluate the Antiproteinuric Effect of Renin Inhibition With Aliskiren in Patients With Idiopathic Membranous Nephropathy
Status: Archived
Updated: 1/1/1970
Mayo Clinic College of Medicine
559
mi
from 43215
Rochester, MN
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Aldosterone Breakthrough During Diovan (Valsartan), Tekturna (Aliskiren), and Combination (Valsartan+Aliskiren) Anti-hypertensive Therapy in Patients With Proteinuric Kidney Disease
Status: Archived
Columbia Presbyterian Med Ctr
481
mi
from 43215
New York, NY
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Aldosterone Breakthrough During Diovan (Valsartan), Tekturna (Aliskiren), and Combination (Valsartan+Aliskiren) Anti-hypertensive Therapy in Patients With Proteinuric Kidney Disease
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
481
mi
from 43215
New York, NY
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
492
mi
from 43215
Birmingham, AL
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
492
mi
from 43215
Birmingham, AL
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
3103
mi
from 43215
Anchorage, AK
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
3103
mi
from 43215
Anchorage, AK
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigative Site
1978
mi
from 43215
Mission Hills, CA
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigative Site
1978
mi
from 43215
Mission Hills, CA
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
1943
mi
from 43215
La Mesa, CA
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
1943
mi
from 43215
La Mesa, CA
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
751
mi
from 43215
Daytona Beach, FL
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
751
mi
from 43215
Daytona Beach, FL
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
624
mi
from 43215
Overland Park, KA
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
624
mi
from 43215
Overland Park, KA
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigative Site
617
mi
from 43215
North Kansas City, MO
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigative Site
617
mi
from 43215
North Kansas City, MO
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
438
mi
from 43215
Lawrence, NJ
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
438
mi
from 43215
Lawrence, NJ
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
477
mi
from 43215
New York, NY
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
477
mi
from 43215
New York, NY
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
127
mi
from 43215
Cleveland, OH
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
127
mi
from 43215
Cleveland, OH
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
416
mi
from 43215
Philadelphia, PA
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
416
mi
from 43215
Philadelphia, PA
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
426
mi
from 43215
Columbia, SC
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
426
mi
from 43215
Columbia, SC
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
1065
mi
from 43215
Austin, TX
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
1065
mi
from 43215
Austin, TX
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Watson Investigational Site
423
mi
from 43215
Norfolk, VA
Study of Silodosin to Facilitate Passage of Urinary Stones
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status: Archived
Updated: 1/1/1970
Watson Investigational Site
423
mi
from 43215
Norfolk, VA
Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
A Multi-centre, Double-blind, Placebo Controlled, Proof of Concept Study to Evaluate the Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
Status: Archived
Brigham & Women's Hospital Women's Health Center
637
mi
from 43215
Chestnut Hill, MA
Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
A Multi-centre, Double-blind, Placebo Controlled, Proof of Concept Study to Evaluate the Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
637
mi
from 43215
Chestnut Hill, MA
Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
A Multi-centre, Double-blind, Placebo Controlled, Proof of Concept Study to Evaluate the Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
Status: Archived
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
A Multi-centre, Double-blind, Placebo Controlled, Proof of Concept Study to Evaluate the Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
Status: Archived
Updated: 1/1/1970
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Velcade for Proliferative Lupus Nephritis
Velcade for Proliferative Lupus Nephritis
Status: Archived
The Rogosin Institute
480
mi
from 43215
, NY
Velcade for Proliferative Lupus Nephritis
Velcade for Proliferative Lupus Nephritis
Status: Archived
Updated: 1/1/1970
The Rogosin Institute
480
mi
from 43215
, NY
Kidney Disease Biomarkers
Kidney Disease Biomarkers
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Kidney Disease Biomarkers
Kidney Disease Biomarkers
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
A Translational Approach to Gitelman Syndrome
A Translational Approach to Gitelman Syndrome
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
A Translational Approach to Gitelman Syndrome
A Translational Approach to Gitelman Syndrome
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
Correction of Glutathione Deficiency for Treatment of Diabetic Nephropathy
Status: Enrolling
Updated:  12/31/1969
South Texas Health Care System, San Antonio, TX
1138
mi
from 43215
San Antonio, TX
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
Correction of Glutathione Deficiency for Treatment of Diabetic Nephropathy
Status: Enrolling
Updated: 12/31/1969
South Texas Health Care System, San Antonio, TX
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine
The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine for the Management of Pain After Surgical Correction of Ureteropelvic Junction Stenosis
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine
The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine for the Management of Pain After Surgical Correction of Ureteropelvic Junction Stenosis
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine
The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine for the Management of Pain After Surgical Correction of Ureteropelvic Junction Stenosis
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Boston
641
mi
from 43215
Boston, MA
The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine
The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine for the Management of Pain After Surgical Correction of Ureteropelvic Junction Stenosis
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Boston
641
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
282
mi
from 43215
Evanston, IL
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
282
mi
from 43215
Evanston, IL
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
163
mi
from 43215
Detroit, MI
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
163
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2107
mi
from 43215
San Francisco, CA
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1154
mi
from 43215
Aurora, CO
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
711
mi
from 43215
Gainesville, FL
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
711
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
563
mi
from 43215
Springfield, MA
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
563
mi
from 43215
Springfield, MA
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
481
mi
from 43215
New York, NY
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
405
mi
from 43215
Bethlehem, PA
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
405
mi
from 43215
Bethlehem, PA
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
331
mi
from 43215
Nashville, TN
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
9459
mi
from 43215
Camperdown,
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
9459
mi
from 43215
Camperdown,
Click here to add this to my saved trials
Rituximab to Prevent Recurrence of Proteinuria
The Use of Rituximab to Prevent Recurrence of Proteinuria in Patients Receiving Kidney Transplant for FSGS
Status: Enrolling
Updated:  12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Rituximab to Prevent Recurrence of Proteinuria
The Use of Rituximab to Prevent Recurrence of Proteinuria in Patients Receiving Kidney Transplant for FSGS
Status: Enrolling
Updated: 12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
MEmbranous Nephropathy Trial Of Rituximab
"A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)"
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
MEmbranous Nephropathy Trial Of Rituximab
"A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)"
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
MEmbranous Nephropathy Trial Of Rituximab
"A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)"
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Scottsdale
1645
mi
from 43215
Scottsdale, AZ
MEmbranous Nephropathy Trial Of Rituximab
"A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)"
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Scottsdale
1645
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials